SEC Form 4 · accession 0001493152-26-035868
Protagenic Therapeutics, Inc.\new · PTIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Garo H Armen
Officer — EXEC. CHAIR & PRINCIPAL OFF. · Director
Period of report
Jul 30, 2026
Accepted (ET)
Aug 3, 2026 · 5:29 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001022899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Jul 30, 2026 | P | 26,291 | $0.1828 | A | 26,291 | D |
Table II — derivative securities
No Table II lines on this filing.